Track topics on Twitter Track topics that are important to you
SoluLinK is the leader in the development of conjugation reagents, easy-to-use linking kits, and conjugation services for the life science research, diagnostics, and pharmaceutical communities. These proprietary products and services provide unique features and benefits used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces including beads, chips and slides. SoluLinK's new HRP-Antibody All-in-One Conjugation Kit is the first in its pipeline of a series of new, easy-to-use All-in-One Conjugation Kits intended to enhance assay performance and measurement for customers in a broad range of markets. SoluLinK markets its products both directly and through distributors and licensing partners world-wide. SoluLinK is a privately held company located in San Diego, California. For more information, please visit www.solulink.com.
SoluLinK is the leader in the development of conjugation reagents, easy-to-use linking kits, and conjugation services for the life science research, diagnostics, and pharmaceutical communities. These ...
We have published hundreds of SoluLinK, Inc. news stories on BioPortfolio along with dozens of SoluLinK, Inc. Clinical Trials and PubMed Articles about SoluLinK, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SoluLinK, Inc. Companies in our database. You can also find out about relevant SoluLinK, Inc. Drugs and Medications on this site too.
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity. This can be a drug or biochemical substance or a cell in an organism or organic sample. ...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...